Although the presence of neuronal nitric oxide synthase (nNOS) has been demonstrated in human clitoral corpus cavernosum, functional evidence for the nitrergic neurotransmission as a nonadrenergic noncholinergic (NANC) transmitter has been limited to animal studies. Here we show that electrical field stimulation elicited reproducible NANC relaxation responses in a clitoral corpus cavernosum, obtained from a 38-y-old woman undergoing clitoral reduction surgery. These relaxation responses were abolished by an inhibitor of NO synthase or tetrodotoxin proving that they were nitrergic in nature and neuronal in origin. Large and small calibre nitrergic nerves were demonstrated with immunohistochemistry using nNOS antibody, which were also immunostained with cholinergic nerve markers. nNOS expression was confirmed using Western blotting. This is the first report to show that NO produced by nNOS within the cholinergic-nitrergic nerves is responsible for the NANC relaxation responses in a human clitoral corpus cavernosum.
Introduction
Nitric oxide (NO) released from postganglionic parasympathetic (cholinergic) nerves relaxes penile vascular and cavernosal smooth muscle to elicit erection. 1 This has been proven to be correct not only in several animal studies but also in human tissue. [2] [3] [4] [5] A similar mechanism of smooth muscle relaxation has been proposed in clitoral corpus cavernosum. Neuronal nitric oxide synthase (nNOS), which synthesises NO from L-arginine, has been shown to be present within the neuronal axons in the human clitoris. 6 However, the functional studies to prove that NO is responsible for the autonomic nerve-mediated relaxation in the human clitoris have been limited to animal tissues. 7 This has been mainly due to low availability, small size and poor viability of the human tissue suitable for a functional study. One approach to solve this problem would be to use clitoral tissue from women who are undergoing clitoral reduction surgery. Although this is a rare situation, we were fortunate enough to be able to use a tissue from a 38-y-old woman who had an idiopathic enlarged clitoris and had no endocrinological or genetic abnormality. The tissue was utilised in functional studies as well as for the immunohistochemistry and the Western blotting.
Materials and methods

Human clitoral corpus cavernosum
The tissue was obtained from a 38-y-old patient who underwent a routine clitoral reduction surgery for cosmetic reasons. The patient did not have any medical, hormonal or genetic abnormality. Virilising conditions such as congenital adrenal hyperplasia or androgen secreting tumours were excluded. The patient completed the Golombok Rust Inventory of Sexual Satisfaction (GRISS) 8 prior to her operation. The clitoris was degloved and the urethral plate left attached to the glans. The entire body of the clitoris was exposed to below the bifurcation of the corporal bodies. The neurovascular bundle was identified and preserved. Erectile tissue was excised, taking care not to damage the neurovascular bundle. The proximal ends of the erectile tissue were oversewn for haemostasis. The glans was then sewn onto the stumps of the corporal bodies ( Figure 1 ).
This study has been approved by the Joint University College London and University College London Hospital Committees on the Ethics of Human Research (file no. 01/0131). The patient provided written informed consent to the study.
The tissue was transferred from the operating theatre to the research laboratory in modified Krebs' solution (composition in mM: NaCl 136.9, KCl 2.7, CaCl 2 1.8, MgSO 4 0.6, NaHCO 3 11.9, KH 2 PO 4 0.5, glucose 11.5, indomethacin 0.01, dexamethasone 0.01 and gassed with 5% CO 2 in O 2 ; pH 7.0-7.2) at ambient temperature within 30 min. The cavernosal tissue was then divided into three parts for functional, immunohistochemical and Western blotting studies.
Functional studies
The tissue piece was cut into four strips (2 Â 4 mm) and was cleaned and mounted horizontally between two ring electrodes (4 mm diameter) in superfusion chambers (371C) as described previously for rabbit clitoral corpus cavernosum. 7 The chambers were perfused with modified Krebs' solution at a constant flow of 1.0 ml/min by means of peristaltic pumps (Miniplus 2, Gilson). One end of the preparation was tied to a Grass FT 03C force-displacement transducer connected to a Linearcorder WR 3101 (Graphtec, Tokyo, Japan) for registration of isometric changes in tension. The preparations were stretched until they reached approximately the in situ length (0.8-1 g) and allowed to equilibrate for 90 min. The preparations were stimulated electrically (electrical field stimulation (EFS)) for 5 s with trains of rectangular pulses of 50 V, 0.3 ms pulse duration and at a range of frequency of 1-50 Hz, delivered by Grass S88 stimulators. The mechanical responses were also recorded on a computer by a specialised data acquisition system (Axon Instruments, USA).
Immunohistochemistry
After fixation in 4% paraformaldehyde overnight at room temperature, the tissue was transferred into 30% sucrose in phosphate buffer and kept at 41C overnight. The samples were then frozen in OCT compound (BDH, UK) and serial cryosections at 20 mm intervals were obtained using a cryostat (À221C; Leica, 2800 Frigocut-E, Germany). The sections were dried on gelatine-coated slides for 2 h at room temperature and then incubated with PBS containing 0.1% Triton X-100 and 5% of the serum of the species from which the secondary antibody was obtained. Then the slides were incubated with antibodies against nNOS (raised in sheep, K205; 
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SM Creighton et al USA), tyrosine hydroxylase (TH; Chemicon; 1:200) and b-tubulin (Chemicon; 1:1000) overnight followed by detection with appropriate fluoresceinor rhodamine-conjugated secondary antibodies. The images were obtained using a laser-scanning confocal microscope (Leica TCS-DMRE, Germany). No fluorescence was observed when the primary antibody was omitted.
Western blotting
The frozen tissue was pulverised using a stainless steel pestle and mortar on dry ice, homogenised in 20 mM HEPES, 1mM EDTA, 0.2 M sucrose, 20 mg/ml soyabean trypsin inhibitor, 20 mg/ml leupeptin, 5 mg/ ml pepstatin A, 5 mM DL-dithiothreitol (DTT), 5 mg/ ml E-64, 5 mg/ml bestatin, 5 mg/ml aprotinin and 10 mg/ml 3-4-DCL (pH 7.2) at 41C. The cell membranes were disrupted using a sonicator at 20 mm for 5 s at 41C. The lysate was centrifuged at 13 000 g for 15 min at 41C. The protein concentration in the supernatant was measured, and 100 mg of protein was run on 10% polyacrylamide SDS gels, and then transferred to nitrocellulose membranes. The blots were incubated overnight with monoclonal nNOS antibody (Transduction Laboratories, UK; 1:2000) and then with HRP-conjugated anti-mouse IgG (Vector Labs, UK; 1:2000) for 2 h. The reactive bands were detected with a luminol-based kit (Pierce, UK).
Statistical analysis
Relaxation to EFS was measured as the area above the trace from the start of the stimulation until the tissue returned to resting tone (using Clampfit Software, Axon Instruments, USA 
Results
Functional studies
EFS of the cavernosal strips elicited small (o0.01 g) contractions. These were completely abolished after addition of guanethidine (10 mM). Further addition of scopolamine (10 mM) was without any effect. The tone of the tissues was elevated with phenylephrine (30 mM). Under these conditions, EFS elicited reproducible relaxation responses, which were frequency-dependent (Figures 2 and 3 ). These relaxation responses were significantly inhibited with an inhibitor of NOS (N G -nitro-L-arginine methyl ester (L-NAME), 500 mM; Figures 2 and 3) . Addition of the substrate of NO, L-arginine (1 mM), partially reversed the inhibition. The remaining relaxation responses were completely inhibited by tetrodotoxin (TTX; 3 mM) (Figure 2 ).
Immunofluorescence nNOS immunostaining was evident in nerve fibrelike structures criss-crossing the entire of the corpus cavernosum. Some of these nerve fibres were large calibre (B3-4 mm) which were usually giving out smaller branches (B1 mm; Figure 4) . Most of the nNOS-positive fibres were also immunostained with antibodies raised against cholinergic nerve markers ChAT or VAChT (Figure 4) . All of the nNOS-positive fibres were also positive for the nonspecific neuronal marker b-tubulin (Figure 4) . None of these fibres were stained with TH antibody, which is a marker for sympathetic (noradrenergic) nerves (not shown). . These relaxation responses were abolished in the presence of an inhibitor of NOS (L-NAME; 500 mM). This inhibition was partially reversed by L-arginine (L-arg; 1 mM). TTX (3 mM) completely inhibited the response.
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Western blotting
A band corresponding to nNOS at B160 kDa was observed in the Western blotting of crude extracts of human clitoral corpus cavernosum ( Figure 5 ). Extracts of rat pituitary and rat brain were used as positive controls in which similar bands were observed ( Figure 5 ).
Discussion
Studies on the functional activity of the inhibitory NANC transmission in the clitoral corpus cavernosum have been limited to animal tissues. We have previously shown that EFS elicits NANC relaxation responses in the rabbit clitoral corpus cavernosum. 7 These responses were completely inhibited by an inhibitor of NOS (TTX) or an inhibitor of soluble guanylate cyclase (sGC), suggesting that these responses are nitrergic in nature, neuronal in origin and are mediated by sGC-cGMP pathway. 7 Furthermore, these nitrergic responses were potentiated with PDE5 inhibitors zaprinast 7 and sildenafil. 10 Expression of nNOS in the nerve fibres within the human clitoral corpus cavernosum has been demonstrated. 7 More recently, PDE5 inhibitor vardenafil has been shown to enhance clitoral blood flow response to pelvic nerve stimulation in anaesthetised dog.
11 All these studies demonstrate a pivotal role for nitrergic neurotransmission to elicit smooth muscle relaxation in the clitoral corpus cavernosum. However, functional data from human study to support this are lacking. This has been due to low availability of normal human tissue, the size of tissue samples being too small for functional studies and the poor viability of the tissue. In this study we used clitoral corpus cavernosum from a woman who was undergoing clitoral reduction surgery for cosmetic reasons. Since she did not have any medical, hormonal or genetic abnormalities and she was premenopausal, she was an ideal candidate for this study. Elective clitoral reduction surgery in normal adult women is extremely rare; hence, our study is limited to one subject.
The cavernosal strips responded with a small contraction to EFS which was blocked with guanethidine, suggesting that sympathetic (noradrenergic) innervation is responsible for the nerve-induced contraction responses in this tissue as previously shown in rabbit tissue. 7 After blocking of cholinergic neurotransmission with scopolamine and elevation of the tone with phenylephrine, EFS elicited reproducible, frequencydependent NANC relaxation responses. These relaxations were completely inhibited in the presence of an inhibitor of NOS, proving that NO is the sole neurotransmitter responsible for the NANC relaxation response in this tissue. This was further confirmed with partial reversal of the inhibition with the substrate of NOS. The remaining relaxation responses were abolished in the presence of TTX, further confirming the neuronal origin of the responses. Overall, these findings confirm that nitrergic neurotransmission is responsible for the nerve-induced relaxation of clitoral cavernosal smooth muscle.
These findings are in agreement with our previous study with rabbit clitoris 7 showing that NO mediates Nitrergic neurotransmission in human clitoris SM Creighton et al the whole of the NANC relaxation response in this tissue. However, in the rabbit vagina NO mediates only 25-30% of the NANC relaxation response, the remaining majority seems to be mediated by a yet unknown neurotransmitter. 12, 13 Further studies with human vagina will be required to verify the functional existence of this elusive transmitter. 
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In this study we also confirmed the nNOS immunoreactivity in nerve fibres within the human clitoral corpus cavernosum in accordance with a previous study. 6 Most of the nNOS-positive nerve fibres were also positive for ChAT or VAChT, suggesting that they are postganglionic cholinergic nerve fibres. This is in accordance with a previous study in the penile corpus cavernosum 14, 15 where nNOS and VAChT have been shown to be coexpressed in the same nerve fibres. To our knowledge our study is the first to show cholinergic origin of nitrergic nerve fibres in a human clitoral corpus cavernosum.
In our study we did not find any evidence of tyrosine hydroxylase expression in the nNOS-positive or VAChT-positive nerves suggesting that cholinergic/nitrergic nerve fibres are separate from sympathetic nerve fibres. This is in accordance with previous studies with penile tissues. 14, 15 The patient completed the Golombok Rust Inventory for Sexual Satisfaction (GRISS) 8 prior to her operation. The overall score for this patient was at a level consistent with normal sexual function, although the orgasm subscore was abnormal, indicating difficulties in this area. The patient will be asked to repeat the GRISS questionnaire in 6-12 months postoperatively. It will be interesting to assess any change in her orgasmic function.
A deficiency in clitoral tumescence has been suggested to be important in the pathogenesis of female sexual arousal disorder (FSAD). 16 PDE5 inhibitors have been implicated for the treatment of FSAD. 17 Our study showing a functional role of nitrergic neurotransmission in the human clitoral corpus cavernosum further supports this view.
